PEBP1 and nonpapillary renal cell carcinoma: Our group has been the first one to demonstrate, in ccRCC, that the expression levels of RKIP and pRKIP in urine reflected those of tumour tissues, thus laying the groundwork for the potential use of RKIP and pRKIP for diagnostic and prognostic screening of subjects at risk for this pathology [32,76].